Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility. - Wikidata - awgldk - TriplyDB

Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.

Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.

http://www.wikidata.org/entity/Q37565250

about

Allele rs2010963 C of the VEGFA gene is associated with the decreased risk of primary varicose veins in ethnic Russians.

P2860

Q51021472-C9F65C55-06BC-40AE-834A-43F44BF4D3EC

P2860

Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.

http://www.wikidata.org/entity/Q37565250

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@en

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@nl

type

label

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@en

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@nl

prefLabel

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@en

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@nl

P1433

Q37565250-52B75052-C6B3-40D8-B9BD-6FF0EBEA3206

P1476

Q37565250-AD187C31-7BD8-4416-98E8-5A6D50DCAE5C

P2093

Q37565250-5694372C-ECFC-4319-A147-58C83ACA75C4

Q37565250-6324191C-F4CC-4F3C-AB34-C3D9459080EA

Q37565250-8C2C7088-71B6-4647-B046-E770D08D5FA3

Q37565250-AC1004F6-271A-4350-B2DA-114CBE1D7BD9

Q37565250-BBF2DC37-FAC6-4001-87B8-D42976DDA3F5

Q37565250-E35EA673-6E0B-464C-91A9-93B3204DB876

Q37565250-FFDB84C9-5FE1-4364-994C-2B140DFEB919

P2860

Q37565250-01A088CA-540F-4D21-8B5D-BE02E8636784

Q37565250-05C14C94-7FFB-4FAE-973B-90259DA9543C

Q37565250-06F4843E-052D-4E45-B112-DCC3D362D6AA

Q37565250-082F7A18-23EC-4724-870F-5194338B386D

Q37565250-09DAF6F9-2163-4012-96E4-874730FF47B8

Q37565250-115B3328-C07A-4EFB-ABB9-54F16F38D103

Q37565250-2E684A6E-241B-438E-B25D-7634AD66616E

Q37565250-34B1AD78-1253-4F15-AF6E-3F25A06BF651

Q37565250-36AF1AAE-D12E-40D5-AEEE-3994765D9ECA

Q37565250-3F436F3A-1A4E-4885-94D9-3A9DB38E86EE

P304

Q37565250-7E0ED9D8-A187-42D3-836E-78FE3992A57C

P31

Q37565250-7afe71ca-eabd-47aa-9e4b-7d5c00404e26

Q37565250-E7E3F873-C5AE-4F6C-80DC-DB3BAC74A7D1

P356

Q37565250-CC9BD561-A3E9-4744-B83C-0BA6FFE0E1CC

P407

Q37565250-46F93BEF-8D58-46DF-B045-62B67C1A3DD7

P433

Q37565250-2C236C77-BF40-4CF0-A67C-39AFEF509E15

P478

Q37565250-7593EE50-E96E-4BF4-AC1E-C79C8A1B9D25

P577

Q37565250-E952A853-39DE-45A8-B24D-01F16E608B89

P698

Q37565250-0DADEECD-25A3-4055-B7F0-0A77AE097E9F

P921

Q37565250-98E85939-739F-4856-AAFD-4D8E1B0A964F

P932

Q37565250-19C0C94B-821E-4430-A507-504ACDFA9BA4

P356

ONCOTARGET.10278

P1433

P1476

Vascular endothelial growth fa ...... h osteosarcoma susceptibility.

@en

P2093

Ai-Ling Zhan

http://www.w3.org/2001/XMLSchema#string

Lan Zhou

http://www.w3.org/2001/XMLSchema#string

Ming Shen

http://www.w3.org/2001/XMLSchema#string

Qian Jiang

http://www.w3.org/2001/XMLSchema#string

Xin-Ya Du

http://www.w3.org/2001/XMLSchema#string

Yu-Ming Niu

http://www.w3.org/2001/XMLSchema#string

Yuan-Yuan Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analysis in clinical trials

Statistical aspects of the analysis of data from retrospective studies of disease

Angiogenesis in cancer and other diseases

Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis

Molecular mechanisms and clinical applications of angiogenesis

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study.

VEGF receptor signaling in tumor angiogenesis.

Interleukin-17 gene polymorphisms contribute to cancer risk

P304

47711-47719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10278

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27351225

http://www.w3.org/2001/XMLSchema#string

P921

P932

5216973

http://www.w3.org/2001/XMLSchema#string